Mineralys Therapeutics’ $192 Million Initial Public Offering

Pietro Martinoia
Tagged:

Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters.Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now